Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1985 1
1989 1
1994 3
1995 1
1996 1
1997 3
1998 5
1999 8
2000 7
2001 10
2002 5
2003 18
2004 22
2005 21
2006 15
2007 12
2008 18
2009 15
2010 12
2011 16
2012 29
2013 15
2014 28
2015 27
2016 28
2017 38
2018 38
2019 45
2020 30
Text availability
Article attribute
Article type
Publication date

Search Results

437 results
Results by year
Filters applied: . Clear all
Page 1
Cannabis and multiple sclerosis.
Ingram G, Pearson OR. Ingram G, et al. Pract Neurol. 2019 Aug;19(4):310-315. doi: 10.1136/practneurol-2018-002137. Epub 2019 Jun 14. Pract Neurol. 2019. PMID: 31201234 Review.
Around half of patients with multiple sclerosis admit to previous or current cannabis use for medicinal purposes and would endorse legalisation. ...Here we address what adult neurologists need to know about cannabis and its use in multiple sc
Around half of patients with multiple sclerosis admit to previous or current cannabis use for medicinal purposes and wo …
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.
Nielsen S, Germanos R, Weier M, Pollard J, Degenhardt L, Hall W, Buckley N, Farrell M. Nielsen S, et al. Curr Neurol Neurosci Rep. 2018 Feb 13;18(2):8. doi: 10.1007/s11910-018-0814-x. Curr Neurol Neurosci Rep. 2018. PMID: 29442178 Review.
PURPOSE OF REVIEW: Pharmaceutical cannabinoids such as nabiximols, nabilone and dronabinol, and plant-based cannabinoids have been investigated for their therapeutic potential in treating multiple sclerosis (MS) symptoms. This review of reviews aimed to synthesise f …
PURPOSE OF REVIEW: Pharmaceutical cannabinoids such as nabiximols, nabilone and dronabinol, and plant-based cannabinoids have been investiga …
[Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L, Minozzi S, Mitrova Z, Parmelli E, Saulle R, Cruciani F, Vecchi S, Davoli M. Amato L, et al. Epidemiol Prev. 2017 Sep-Dec;41(5-6):279-293. doi: 10.19191/EP17.5-6.AD01.069. Epidemiol Prev. 2017. PMID: 29119763 Free article. Review. Italian.
RESULTS: 41 trials (4,550 participants) were included; 15 studies considered efficacy and safety of cannabis for patients with multiple sclerosis, 12 for patients with chronic pain, and 14 for patients with cancer receiving chemotherapy. ...Concerning the eff …
RESULTS: 41 trials (4,550 participants) were included; 15 studies considered efficacy and safety of cannabis for patients with mul
Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation.
Kindred JH, Li K, Ketelhut NB, Proessl F, Fling BW, Honce JM, Shaffer WR, Rudroff T. Kindred JH, et al. Complement Ther Med. 2017 Aug;33:99-104. doi: 10.1016/j.ctim.2017.07.002. Epub 2017 Jul 10. Complement Ther Med. 2017. PMID: 28735833
OBJECTIVES: Cannabis has been used for medicinal purpose for thousands of years; however the positive and negative effects of cannabis use in Parkinson's disease (PD) and Multiple Sclerosis (MS) are mostly unknown. ...Fox Foundation and the National …
OBJECTIVES: Cannabis has been used for medicinal purpose for thousands of years; however the positive and negative effects of cann
Phytochemistry of Cannabis sativa L.
ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A. ElSohly MA, et al. Prog Chem Org Nat Prod. 2017;103:1-36. doi: 10.1007/978-3-319-45541-9_1. Prog Chem Org Nat Prod. 2017. PMID: 28120229 Review.
Today, more than 560 constituents have been identified in cannabis. The recent discoveries of the medicinal properties of cannabis and the cannabinoids in addition to their potential applications in the treatment of a number of serious illnesses, such as glaucoma, d …
Today, more than 560 constituents have been identified in cannabis. The recent discoveries of the medicinal properties of cannabis
Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E. Weinkle L, et al. Mult Scler Relat Disord. 2019 Jan;27:383-390. doi: 10.1016/j.msard.2018.11.022. Epub 2018 Nov 20. Mult Scler Relat Disord. 2019. PMID: 30502644
BACKGROUND: Studies suggest cannabis may improve symptoms like pain and muscle spasticity in patients with multiple sclerosis (PwMS). ...The purpose of the current study was to evaluate cannabis use among PwMS at a large academic multiple scl
BACKGROUND: Studies suggest cannabis may improve symptoms like pain and muscle spasticity in patients with multiple scleros
Caring for people with multiple sclerosis who use cannabis for symptom control.
Daly L, Gibson CE, Dewing J. Daly L, et al. Br J Community Nurs. 2019 Jun 2;24(6):257. doi: 10.12968/bjcn.2019.24.6.265. Br J Community Nurs. 2019. PMID: 31166770 Review.
Research suggests that a large proportion of people living with multiple sclerosis (PwMS) are using cannabis to self-manage symptoms, or at least believe there are potential benefits in using this drug. Since community nurses are frontline caregivers, they ar …
Research suggests that a large proportion of people living with multiple sclerosis (PwMS) are using cannabis to self-ma …
Cannabis for Neuropathic Pain in Multiple Sclerosis-High Expectations, Poor Data.
Rudroff T. Rudroff T. Front Pharmacol. 2019 Oct 22;10:1239. doi: 10.3389/fphar.2019.01239. eCollection 2019. Front Pharmacol. 2019. PMID: 31695613 Free PMC article. No abstract available.
Cannabis-based product use in a multiple sclerosis cohort.
Schabas AJ, Vukojevic V, Taylor C, Thu Z, Badyal A, Chan JK, Devonshire V, Traboulsee A, Sayao AL, Carruthers R. Schabas AJ, et al. Mult Scler J Exp Transl Clin. 2019 Sep 25;5(3):2055217319869360. doi: 10.1177/2055217319869360. eCollection 2019 Jul-Sep. Mult Scler J Exp Transl Clin. 2019. PMID: 31598330 Free PMC article.
OBJECTIVE: The objective of this study was to characterize the use of cannabis-based products (CBPs) by multiple sclerosis (MS) patients who attend the University of British Columbia Hospital (UBCH) MS clinic. ...EMR data was available for 561 MS patients whe …
OBJECTIVE: The objective of this study was to characterize the use of cannabis-based products (CBPs) by multiple sclerosis
A Review of Herbal Therapy in Multiple Sclerosis.
Mojaverrostami S, Bojnordi MN, Ghasemi-Kasman M, Ebrahimzadeh MA, Hamidabadi HG. Mojaverrostami S, et al. Adv Pharm Bull. 2018 Nov;8(4):575-590. doi: 10.15171/apb.2018.066. Epub 2018 Nov 29. Adv Pharm Bull. 2018. PMID: 30607330 Free PMC article. Review.
Multiple sclerosis is a complex autoimmune disorder which characterized by demyelination and axonal loss in the central nervous system (CNS). ...Recently, herbal therapies represent a promising therapeutic approach for multiple sclerosis disease. Here,
Multiple sclerosis is a complex autoimmune disorder which characterized by demyelination and axonal loss in the central nervou
437 results
Jump to page
Feedback